CPHI Experts Report that Small to Mid-sized US CDMOs Must Invest Now to Benefit from 2025 Contract Funding Surge
BioPharm
MAY 2, 2024
Key areas to invest include manufacturing process improvements, quality management, and AI.
52 
Genentech to open new high-tech biologics facility
European Pharmaceutical Review
FEBRUARY 15, 2023
When operational in early 2025, the new facility will be the first commercial biopharma manufacturing facility to incorporate the latest manufacturing technologies along with in-house process improvements for increased flexibility, speed and output under one roof.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Quality Essentials Review: Advancing Medication Therapy Management Quality Measurement
PQA
OCTOBER 22, 2024
Cooke, Research Associate Professor at the University of Maryland School of Pharmacy, Aaron Larson, VP of Health Plan Quality Analytics at UnitedHealth Group and Anita Pothen Skaria, Vice President of Quality and Process Improvement with Centene Corporation.
Considerations for a Decentralized Manufacturing Paradigm
ISPE
SEPTEMBER 11, 2023
AI Technology There are multiple potential future applications of AI technology that can support more efficient technology transfer, scale-up, site monitoring, and regulatory submission processes (see Figure 2). EMA Regulatory Science to 2025: Strategic Reflection.” This can simplify future scale-up and technology transfer.
Let's personalize your content